Showing results (4331-4340 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|May 24, 2000
Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatographyS Maleki, S Graves, S Becker, et al.Clinical Therapeutics|May 24, 2000
Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detectionD W Holt, T Lee, A JohnstonClinical Therapeutics|May 24, 2000
Toxicity and efficacy of sirolimus: relationship to whole-blood concentrationsH U Meier-Kriesche, B KaplanClinical Therapeutics|May 24, 2000
Clinical pharmacokinetics and therapeutic drug monitoring of sirolimusA MacDonald, J Scarola, J T Burke, et al.Clinical Therapeutics|July 13, 2000
The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infectionR Elion, S Kaul, C Knupp, et al.Clinical Therapeutics|July 13, 2000
Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study GroupM A Nemeth, J McCarty, W M Gooch, et al.Clinical Therapeutics|July 13, 2000
Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusionD S Burgess, K K Summers, T C HardinClinical Therapeutics|July 13, 2000
Suboptimal use of antidepressants in the elderly: a population-based study in Nova ScotiaC Rojas-Fernandez, V S Thomas, D Carver, et al.Clinical Therapeutics|July 13, 2000
The impact of race and fractures on mortality in a postmenopausal Medicaid populationJ A Kotzan, B C Martin, J H Reeves, et al.Clinical Therapeutics|July 13, 2000
Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluationsO Montagne, I Vedel, I Durand-ZaleskiPageof 680